Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Isr Med Assoc J ; 3(2): 151-4, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11344828

RESUMO

OBJECTIVE: To study whether retinolpalmitate, beta-carotene or lycopene could prevent liver cirrhosis induced by thioacetamide in rats. METHODS: In the control group liver cirrhosis was induced in male Wistar rats by intraperitoneal injections of TAA 200 mg/kg for 12 weeks. The three study groups received in addition to TAA either beta-carotene, lycopene or retinopalmitate by gavage through an orogastric tube. Histopathological analysis and determination of the hydroxyproline contents of the livers were performed at the end of the protocol. RESULTS: Rats treated with beta-carotene and TAA had lower histopathologic scores and reduced levels of hepatic hydroxyproline (P = 0.02) than those treated by TAA alone. A trend of decreased fibrosis was observed in the rats treated with lycopene and TAA although this lacked statistical significance. CONCLUSIONS: Beta-carotene attenuated liver cirrhosis induced by TAA in rats. The mechanism may be related to effects on hepatic stellate cells or to scavenging of free radicals by beta-carotene. Retinolpalmitate and lycopen had no significant beneficial effect.


Assuntos
Cirrose Hepática Experimental/tratamento farmacológico , Cirrose Hepática Experimental/patologia , Fígado/patologia , beta Caroteno/farmacologia , Análise de Variância , Animais , Modelos Animais de Doenças , Imuno-Histoquímica , Fígado/efeitos dos fármacos , Cirrose Hepática Experimental/induzido quimicamente , Masculino , Ratos , Ratos Wistar , Valores de Referência , Tioacetamida , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...